To assess whether these in vitro results are also clinically applicable, we analyzed the correlation of miR-202 and HK2 expressions in 15 CML patient samples by qRT-PCR. This evidence concerns the gene HK2 and chronic myelogenous leukemia, BCR-ABL1 positive.